FDA's actions may lead to political backlash.
UniQure faces increased scrutiny from regulators.
Potential implications for drug approval processes.
Strategic implications in focus: Recent FDA decisions could complicate the Trump administration's relationship with drugmaker UniQure.
FDA's actions may lead to political backlash.
UniQure faces increased scrutiny from regulators.
Potential implications for drug approval processes.